# Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

> **NCT00115570** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 572 (actual)

## Conditions studied

- Diabetes Mellitus, Insulin-Dependent

## Interventions

- **DRUG:** Insulin glulisine
- **DRUG:** insulin lispro
- **DRUG:** insulin glargine
- **DRUG:** NPH insulin

## Key facts

- **NCT ID:** NCT00115570
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115570, "Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00115570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*